In our TNF-α+TCA injury model, both norUDCA and UDCA treatments ameliorated the loss of cyst diameter associated with injury, suppressed the upregulation of cholangiocyte-reactive phenotype markers, and reduced LDH activity associated with cytotoxic effects of injury. The gene discussed is TNF; the disease is cyst.